METHODS OF CHARACTERIZING DRUG ACTIVITIES USING CONSENSUS PROFILES

Patent №

US 6,801,859

Granted

2004-10-05

Filed 1998

Owner

ROSETTA INPHARMATICS, INC.

+1 more

AI components

2

planning · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09220142

The present invention provides methods for enhanced detection of biological response profiles. In particular, the methods of this invention allow for the detection of biological response patterns, such as gene expression patterns, in response to different drug treatments. The methods of the invention also allow the determination of a “consensus profile” which describes a particular class or type of biological response. In certain embodiments the consensus profile may describe the biological response of a particular group or class of drugs. In other embodiments, the consensus profile may describe an “ideal” biological response such as one associated with a desired therapeutic effect. The methods of the present invention also allow for the comparison of different biological responses. Thus, the methods of the invention may be used, e.g., to identify and/or study new drugs.

PlanningAI hardwareG16B 40/30G16B 25/10G16B 40/00G16B 25/00

AI classification

AI hardware0.91
Planning0.74
Machine learning0.35
Evolutionary computation0.10
Knowledge representation0.01
Vision0.00
Natural language0.00
Speech0.00

Ownership

ROSETTA INPHARMATICS, INC.

assignment · 97790533

MICROSOFT CORPORATION

assignment · 237080345

Assignors

FRIEND, STEPHEN H., STOUGHTON, ROLAND, HE, YUDONG, FRIEND, STEPHEN H., STOUGHTON, ROLAND, HE, YUDONG

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC